Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Man Kit Siu; Wassim Abou-Kheir; Juan Juan Yin; Yung Sheng Chang; Ben Barrett; Florent Suau; Orla Casey; Wei Yu Chen; Lei Fang; Paul Hynes; Yao Yu Hsieh; Yen Nien Liu; Jiaoti Huang; Kathleen Kelly

doi:10.18632/oncotarget.26020

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Man Kit Siu, Wassim Abou-Kheir, Juan Juan Yin, Yung Sheng Chang, Ben Barrett, Florent Suau, Orla Casey, Wei Yu Chen, Lei Fang, Paul Hynes, Yao Yu Hsieh, Yen Nien Liu, Jiaoti Huang, Kathleen Kelly

Research output: Contribution to journal › Comment/debate › peer-review

4 Citations (Scopus)

Abstract

This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Original language	English
Pages (from-to)	32403
Number of pages	1
Journal	Oncotarget
Volume	9
Issue number	64
DOIs	https://doi.org/10.18632/oncotarget.26020
Publication status	Published - Aug 17 2018

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.18632/oncotarget.26020

Cite this

Siu, M. K., Abou-Kheir, W., Yin, J. J., Chang, Y. S., Barrett, B., Suau, F., Casey, O., Chen, W. Y., Fang, L., Hynes, P., Hsieh, Y. Y., Liu, Y. N., Huang, J., & Kelly, K. (2018). Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994. Oncotarget, 9(64), 32403. https://doi.org/10.18632/oncotarget.26020

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994. / Siu, Man Kit; Abou-Kheir, Wassim; Yin, Juan Juan et al.
In: Oncotarget, Vol. 9, No. 64, 17.08.2018, p. 32403.

Research output: Contribution to journal › Comment/debate › peer-review

Siu, MK, Abou-Kheir, W, Yin, JJ, Chang, YS, Barrett, B, Suau, F, Casey, O, Chen, WY, Fang, L, Hynes, P, Hsieh, YY , Liu, YN, Huang, J & Kelly, K 2018, 'Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994', Oncotarget, vol. 9, no. 64, pp. 32403. https://doi.org/10.18632/oncotarget.26020

@article{79bfee96310947239f191b500b85ea0b,

title = "Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994",

abstract = "This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.",

author = "Siu, {Man Kit} and Wassim Abou-Kheir and Yin, {Juan Juan} and Chang, {Yung Sheng} and Ben Barrett and Florent Suau and Orla Casey and Chen, {Wei Yu} and Lei Fang and Paul Hynes and Hsieh, {Yao Yu} and Liu, {Yen Nien} and Jiaoti Huang and Kathleen Kelly",

note = "Publisher Copyright: {\textcopyright} 2018, Siu et al.",

year = "2018",

month = aug,

day = "17",

doi = "10.18632/oncotarget.26020",

language = "English",

volume = "9",

pages = "32403",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "64",

}

TY - JOUR

T1 - Correction

T2 - Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

AU - Siu, Man Kit

AU - Abou-Kheir, Wassim

AU - Yin, Juan Juan

AU - Chang, Yung Sheng

AU - Barrett, Ben

AU - Suau, Florent

AU - Casey, Orla

AU - Chen, Wei Yu

AU - Fang, Lei

AU - Hynes, Paul

AU - Hsieh, Yao Yu

AU - Liu, Yen Nien

AU - Huang, Jiaoti

AU - Kelly, Kathleen

PY - 2018/8/17

Y1 - 2018/8/17

N2 - This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

AB - This article has been corrected: The author affiliation is given below: Yao-Yu Hsieh1,6,9 9 Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

UR - http://www.scopus.com/inward/record.url?scp=85051835232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051835232&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.26020

DO - 10.18632/oncotarget.26020

M3 - Comment/debate

AN - SCOPUS:85051835232

SN - 1949-2553

VL - 9

SP - 32403

JO - Oncotarget

JF - Oncotarget

IS - 64

ER -

Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance [Oncotarget. 5, (2014), 3770-3784]doi 10.18632/oncotarget.1994

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this